Literature DB >> 22992116

High efficiency restriction enzyme-free linear amplification-mediated polymerase chain reaction approach for tracking lentiviral integration sites does not abrogate retrieval bias.

Chuanfeng Wu1, Alexander Jares, Thomas Winkler, Jianjun Xie, Jean-Yves Metais, Cynthia E Dunbar.   

Abstract

Retroviral vectors are an efficient and widely employed means of introducing an exogenous expression cassette into target cells. These vectors have been shown to integrate semi-randomly into the cellular genome, and can be associated with genotoxicity due to impact on expression of proximate genes. Therefore, efficient and accurate integration site analysis, while quantifying contributions of individual vector-containing clones, is desirable. Linear amplification-mediated polymerase chain reaction (LAM-PCR) is a widely used technique for identifying integrated proviral and host genomic DNA junctions. However, LAM-PCR is subject to selection bias inherent in the reliance of the assay on the presence of a restriction enzyme-cutting site adjacent to a retrievable integration site, and it is further limited by an inability to discriminate prior to sequencing between the flanking genomic DNA of interest and uninformative internal vector DNA. We report a modified restriction enzyme-free LAM-PCR (Re-free LAM-PCR) approach that is less time and labor intensive compared to conventional LAM-PCR, but in contrast to some other nonrestrictive methods, compares in efficiency and sensitivity, excludes retrieval of uninformative internal vector sequences, and allows retrieval of integration sites unbiased by the presence of nearby restriction sites. However, we report that Re-free LAM-PCR remains inaccurate for quantitation of the relative contributions of individual integration site-containing clones in a polyclonal setting, suggesting that bias in LAM-PCR retrieval of integration sites is not wholly explained by restriction enzyme-related factors.

Mesh:

Year:  2012        PMID: 22992116      PMCID: PMC3555095          DOI: 10.1089/hum.2012.082

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  29 in total

Review 1.  Hematopoietic stem cell engineering at a crossroads.

Authors:  Isabelle Rivière; Cynthia E Dunbar; Michel Sadelain
Journal:  Blood       Date:  2011-11-17       Impact factor: 22.113

2.  You can count on this: barcoded hematopoietic stem cells.

Authors:  Hanno Glimm; Claudia R Ball; Christof von Kalle
Journal:  Cell Stem Cell       Date:  2011-11-04       Impact factor: 24.633

3.  Multiple displacement amplification enables large-scale clonal analysis following retroviral gene therapy.

Authors:  S Bleier; P Maier; H Allgayer; F Wenz; W J Zeller; S Fruehauf; S Laufs
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

4.  Detection of retroviral integration sites by linear amplification-mediated PCR and tracking of individual integration clones in different samples.

Authors:  Manfred Schmidt; Kerstin Schwarzwaelder; Cynthia C Bartholomae; Hanno Glimm; Christof von Kalle
Journal:  Methods Mol Biol       Date:  2009

5.  Flanking-sequence exponential anchored-polymerase chain reaction amplification: a sensitive and highly specific method for detecting retroviral integrant-host-junction sequences.

Authors:  M A Pule; A Rousseau; J Vera; H E Heslop; M K Brenner; E F Vanin
Journal:  Cytotherapy       Date:  2008       Impact factor: 5.414

Review 6.  Lentiviral vectors: their molecular design, safety, and use in laboratory and preclinical research.

Authors:  Boro Dropulić
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

7.  A genome-wide analysis of lentivector integration sites using targeted sequence capture and next generation sequencing technology.

Authors:  Duran Ustek; Sema Sirma; Ergun Gumus; Muzaffer Arikan; Aris Cakiris; Neslihan Abaci; Jaicy Mathew; Zeliha Emrence; Hulya Azakli; Fulya Cosan; Atilla Cakar; Mahmut Parlak; Olcay Kursun
Journal:  Infect Genet Evol       Date:  2012-05-14       Impact factor: 3.342

8.  Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.

Authors:  Axel Schambach; Jens Bohne; Saurabh Chandra; Elke Will; Geoffrey P Margison; David A Williams; Christopher Baum
Journal:  Mol Ther       Date:  2005-10-12       Impact factor: 11.454

9.  Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

Authors:  Marion G Ott; Manfred Schmidt; Kerstin Schwarzwaelder; Stefan Stein; Ulrich Siler; Ulrike Koehl; Hanno Glimm; Klaus Kühlcke; Andrea Schilz; Hana Kunkel; Sonja Naundorf; Andrea Brinkmann; Annette Deichmann; Marlene Fischer; Claudia Ball; Ingo Pilz; Cynthia Dunbar; Yang Du; Nancy A Jenkins; Neal G Copeland; Ursula Lüthi; Moustapha Hassan; Adrian J Thrasher; Dieter Hoelzer; Christof von Kalle; Reinhard Seger; Manuel Grez
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

10.  Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy.

Authors:  Alessandro Aiuti; Barbara Cassani; Grazia Andolfi; Massimiliano Mirolo; Luca Biasco; Alessandra Recchia; Fabrizia Urbinati; Cristina Valacca; Samantha Scaramuzza; Memet Aker; Shimon Slavin; Matteo Cazzola; Daniela Sartori; Alessandro Ambrosi; Clelia Di Serio; Maria Grazia Roncarolo; Fulvio Mavilio; Claudio Bordignon
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

View more
  18 in total

Review 1.  Development of gene therapy for blood disorders: an update.

Authors:  Arthur W Nienhuis
Journal:  Blood       Date:  2013-07-10       Impact factor: 22.113

2.  Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow.

Authors:  Gajendra W Suryawanshi; Song Xu; Yiming Xie; Tom Chou; Namshin Kim; Irvin S Y Chen; Sanggu Kim
Journal:  J Vis Exp       Date:  2017-06-14       Impact factor: 1.355

3.  Evaluating a ligation-mediated PCR and pyrosequencing method for the detection of clonal contribution in polyclonal retrovirally transduced samples.

Authors:  Martijn H Brugman; Julia D Suerth; Michael Rothe; Sebastian Suerbaum; Axel Schambach; Ute Modlich; Olga Kustikova; Christopher Baum
Journal:  Hum Gene Ther Methods       Date:  2013-03-14       Impact factor: 2.396

4.  Quantitative shearing linear amplification polymerase chain reaction: an improved method for quantifying lentiviral vector insertion sites in transplanted hematopoietic cell systems.

Authors:  Sheng Zhou; Melissa A Bonner; Yong-Dong Wang; Samuel Rapp; Suk See De Ravin; Harry L Malech; Brian P Sorrentino
Journal:  Hum Gene Ther Methods       Date:  2015-02-05       Impact factor: 2.396

5.  Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in mice.

Authors:  Maria Dahl; Alexander Doyle; Karin Olsson; Jan-Eric Månsson; André R A Marques; Mina Mirzaian; Johannes M Aerts; Mats Ehinger; Michael Rothe; Ute Modlich; Axel Schambach; Stefan Karlsson
Journal:  Mol Ther       Date:  2015-02-06       Impact factor: 11.454

6.  Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells.

Authors:  Chuanfeng Wu; Brian Li; Rong Lu; Samson J Koelle; Yanqin Yang; Alexander Jares; Alan E Krouse; Mark Metzger; Frank Liang; Karin Loré; Colin O Wu; Robert E Donahue; Irvin S Y Chen; Irving Weissman; Cynthia E Dunbar
Journal:  Cell Stem Cell       Date:  2014-04-03       Impact factor: 24.633

7.  Path to the clinic: assessment of iPSC-based cell therapies in vivo in a nonhuman primate model.

Authors:  So Gun Hong; Thomas Winkler; Chuanfeng Wu; Vicky Guo; Stefania Pittaluga; Alina Nicolae; Robert E Donahue; Mark E Metzger; Sandra D Price; Naoya Uchida; Sergei A Kuznetsov; Tina Kilts; Li Li; Pamela G Robey; Cynthia E Dunbar
Journal:  Cell Rep       Date:  2014-05-15       Impact factor: 9.423

8.  Development of an inducible caspase-9 safety switch for pluripotent stem cell-based therapies.

Authors:  Chuanfeng Wu; So Gun Hong; Thomas Winkler; David M Spencer; Alexander Jares; Brian Ichwan; Alina Nicolae; Vicky Guo; Andre Larochelle; Cynthia E Dunbar
Journal:  Mol Ther Methods Clin Dev       Date:  2014-11-12       Impact factor: 6.698

9.  High-titer foamy virus vector transduction and integration sites of human CD34(+) cell-derived SCID-repopulating cells.

Authors:  Md Nasimuzzaman; Yoon-Sang Kim; Yong-Dong Wang; Derek A Persons
Journal:  Mol Ther Methods Clin Dev       Date:  2014-06-04       Impact factor: 6.698

10.  High-throughput monitoring of integration site clonality in preclinical and clinical gene therapy studies.

Authors:  Frank A Giordano; Jens-Uwe Appelt; Barbara Link; Sebastian Gerdes; Christina Lehrer; Simone Scholz; Anna Paruzynski; Ingo Roeder; Frederik Wenz; Hanno Glimm; Christof von Kalle; Manuel Grez; Manfred Schmidt; Stephanie Laufs
Journal:  Mol Ther Methods Clin Dev       Date:  2015-04-01       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.